J&J Faces Breast-Growth Claims In 5th Philly Risperdal Trial
The fifth trial in Philadelphia's Risperdal mass tort program began Monday, with counsel for a Tennessee family telling a jury that the antipsychotic drug developed and manufactured by a Johnson &...To view the full article, register now.
Already a subscriber? Click here to view full article